Lawetz C - Search Results

1

Specific inhibition of ribonucleotide reductases by peptides corresponding to the C-terminal of their second subunit.

Cosentino G, Lavallée P, Rakhit S, Plante R, Gaudette Y, Lawetz C, Whitehead PW, Duceppe JS, Lépine-Frenette C, Dansereau N, et al. Cosentino G, et al. Among authors: lawetz c. Biochem Cell Biol. 1991 Jan;69(1):79-83. doi: 10.1139/o91-011. Biochem Cell Biol. 1991. PMID: 2043345

2

Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.

Liuzzi M, Mason SW, Cartier M, Lawetz C, McCollum RS, Dansereau N, Bolger G, Lapeyre N, Gaudette Y, Lagacé L, Massariol MJ, Dô F, Whitehead P, Lamarre L, Scouten E, Bordeleau J, Landry S, Rancourt J, Fazal G, Simoneau B. Liuzzi M, et al. Among authors: lawetz c. J Virol. 2005 Oct;79(20):13105-15. doi: 10.1128/JVI.79.20.13105-13115.2005. J Virol. 2005. PMID: 16189012 Free PMC article.

3

Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor.

Mason SW, Lawetz C, Gaudette Y, Dô F, Scouten E, Lagacé L, Simoneau B, Liuzzi M. Mason SW, et al. Among authors: lawetz c. Nucleic Acids Res. 2004 Sep 8;32(16):4758-67. doi: 10.1093/nar/gkh809. Print 2004. Nucleic Acids Res. 2004. PMID: 15356293 Free PMC article.

4

Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Mason SW, Aberg E, Lawetz C, DeLong R, Whitehead P, Liuzzi M. Mason SW, et al. Among authors: lawetz c. J Virol. 2003 Oct;77(19):10670-6. doi: 10.1128/jvi.77.19.10670-10676.2003. J Virol. 2003. PMID: 12970453 Free PMC article.

5

Improved purification protocol of the HSV-1 protease catalytic domain, using immunoaffinity.

McKercher G, Bonneau PR, Lagacé L, Thibeault D, Massariol MJ, Krogsrud R, Lawetz C, McDonald PC, Cordingley MG. McKercher G, et al. Among authors: lawetz c. Biochem Cell Biol. 1997;75(6):795-801. Biochem Cell Biol. 1997. PMID: 9599670

6

Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.

Duan J, Liuzzi M, Paris W, Lambert M, Lawetz C, Moss N, Jaramillo J, Gauthier J, Déziel R, Cordingley MG. Duan J, et al. Among authors: lawetz c. Antimicrob Agents Chemother. 1998 Jul;42(7):1629-35. doi: 10.1128/AAC.42.7.1629. Antimicrob Agents Chemother. 1998. PMID: 9660995 Free PMC article.

7

The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.

Lawetz C, Liuzzi M. Lawetz C, et al. Antiviral Res. 1998 Jul;39(1):35-46. doi: 10.1016/s0166-3542(98)00028-x. Antiviral Res. 1998. PMID: 9754948

8

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.

Berger KL, Lagacé L, Triki I, Cartier M, Marquis M, Lawetz C, Bethell R, Scherer J, Kukolj G. Berger KL, et al. Among authors: lawetz c. Antimicrob Agents Chemother. 2013 Oct;57(10):4928-36. doi: 10.1128/AAC.00822-13. Epub 2013 Jul 22. Antimicrob Agents Chemother. 2013. PMID: 23877706 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page